Amgen Q4 earnings drop 8.5%
[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”26-07-2011″ enddate=”26-01-2012″ width=”300″ height=”245″] Biotech giant Amgen, which said earlier on Thursday that it would pay $1.2 billion for leukemia drugmaker Micromet, reported fourth-quarter earnings that missed analyst expectations. The Thousand Oaks-based company said fourth-quarter profits fell 8.5 percent to $934 million, or $1.08 per share, on lower sales of Read More →
First California reports record 2011 earnings of $23.4M
[wikichart align=”right” ticker=”NASDAQ:FCAL” showannotations=”true” livequote=”true” startdate=”26-07-2011″ enddate=”26-01-2012″ width=”300″ height=”245″] Westlake Village-based First California Financial Group reported profits of $23.4 million in 2011, a company earnings record. A year earlier, it had earned $1.4 million. “Our record breaking performance in 2011 was driven by the combination of continued successful execution of our strategic plan that focuses Read More →
Venoco’s board agrees to CEO buyout
[Editor’s Note: This story was updated on Jan. 18] Venoco CEO Tim Marquez has agreed to pay $12.50 per share to take his Denver and Carpinteria-based oil and gas company private. In a deal announced shortly before the markets opened on Jan. 17, Venoco said the company had agreed to accept an offer that Marquez, Read More →
Amgen CEO to step down
Kevin Sharer, chairman and CEO of Amgen, is set to retire in May, the Thousand Oaks-based company said on Dec. 15. Current president and chief operating officer Robert Bradway will become the company’s new CEO. Sharer led Amgen, the largest private-sector employer in Ventura County, for 11 years. He oversaw the company’s transition from the Read More →
Amgen wraps up buyback auction
[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”08-06-2011″ enddate=”08-12-2011″ width=”300″ height=”245″] Amgen, based in Thousand Oaks, expects to repurchase 9.6 percent of its outstanding shares at a price of $60 per share after asking shareholders to name their price in a buyback auction. The biotech giant and major Ventura County employer said Dec. 8 it had completed Read More →
